Understanding the causes of CADASIL, a genetic brain disease
Underlying Mechanisms in CADASIL
This study is looking into CADASIL, a genetic condition that affects blood flow in the brain and can lead to memory problems, and it aims to better understand how changes in a specific gene cause these issues, so we can improve diagnosis and find better treatments for patients like you.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10896919 on NIH RePORTER |
What this research studies
This research investigates CADASIL, a genetic condition that affects blood vessels in the brain, leading to cognitive decline and dementia. It focuses on the mutations in the NOTCH3 gene that cause damage to vascular smooth muscle cells, which are crucial for maintaining healthy blood flow. By collaborating with the NIH Clinical Center, the research aims to improve diagnosis and prognosis through better understanding of the disease's clinical manifestations and molecular changes. Patients may be involved in clinical assessments to help define these variations and contribute to the development of targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with CADASIL or those with a family history of the condition.
Not a fit: Patients with cognitive impairments not related to CADASIL or those without a genetic predisposition to the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients suffering from CADASIL and related vascular cognitive impairments.
How similar studies have performed: Previous research has shown promise in understanding genetic contributions to vascular diseases, but this specific investigation into CADASIL is relatively novel.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Iruela-Arispe, M. Luisa — Northwestern University at Chicago
- Study coordinator: Iruela-Arispe, M. Luisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.